(5S)-5-[(1S)-1-[tert-butyl(diphenyl)silyl]oxytridecyl]oxolan-2-one
C33H50O3Si — CID 134839118
Data last refreshed: (MolForge compound catalog, from PubChem)
About (5S)-5-[(1S)-1-[tert-butyl(diphenyl)silyl]oxytridecyl]oxolan-2-one
(5S)-5-[(1S)-1-[tert-butyl(diphenyl)silyl]oxytridecyl]oxolan-2-one (PubChem CID 134839118) has the molecular formula C33H50O3Si and a molecular weight of 522.85 g/mol. Its IUPAC name is (5S)-5-[(1S)-1-[tert-butyl(diphenyl)silyl]oxytridecyl]oxolan-2-one.
Molecular Properties
| Compound Name | (5S)-5-[(1S)-1-[tert-butyl(diphenyl)silyl]oxytridecyl]oxolan-2-one |
|---|---|
| PubChem CID | 134839118 |
| Molecular Formula | C33H50O3Si |
| Molecular Weight | 522.85 g/mol |
| Exact Mass | 522.35 |
| IUPAC Name | (5S)-5-[(1S)-1-[tert-butyl(diphenyl)silyl]oxytridecyl]oxolan-2-one |
| SMILES | CCCCCCCCCCCC[C@H](O[Si](c1ccccc1)(c1ccccc1)C(C)(C)C)[C@@H]1CCC(=O)O1 |
| InChI | InChI=1S/C33H50O3Si/c1-5-6-7-8-9-10-11-12-13-20-25-31(30-26-27-32(34)35-30)36-37(33(2,3)4,28-21-16-14-17-22-28)29-23-18-15-19-24-29/h14-19,21-24,30-31H,5-13,20,25-27H2,1-4H3/t30-,31-/m0/s1 |
| InChIKey | DPWGKUFLBYVVGR-CONSDPRKSA-N |
| XLogP | 7.95 |
| TPSA | 35.53 Ų |
| H-Bond Donors | |
| H-Bond Acceptors | 3 |
| Rotatable Bonds | 16 |
| Heavy Atoms | 37 |
| Complexity | — |
Lipinski Rule of Five
2 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 522.85 |
| LogP ≤ 5 | 7.95 |
| H-Bond Donors ≤ 5 | 0 |
| H-Bond Acceptors ≤ 10 | 3 |
Computed Properties (RDKit)
| Structural Alerts | {'alert_name': 'Aliphatic_long_chain', 'substructure': 'N/A'}, {'alert_name': 'heavy_metal', 'substructure': 'N/A'} |
|---|
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 134839118 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.